vs
Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $28.5M, roughly 1.3× Creative Media & Community Trust Corp). Creative Media & Community Trust Corp runs the higher net margin — -125.8% vs -161.8%, a 36.0% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 3.6%).
Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CMCT vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $28.5M | $38.3M |
| Net Profit | $-11.4M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | -125.6% | -169.0% |
| Net Margin | -125.8% | -161.8% |
| Revenue YoY | 3.6% | 407.0% |
| Net Profit YoY | -11.4% | -4.7% |
| EPS (diluted) | $-3.89 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $28.5M | $38.3M | ||
| Q3 25 | $26.2M | $32.1M | ||
| Q2 25 | $29.7M | $26.4M | ||
| Q1 25 | $32.3M | $16.5M | ||
| Q4 24 | $27.5M | $7.6M | ||
| Q3 24 | $28.6M | $6.1M | ||
| Q2 24 | $34.4M | — | ||
| Q1 24 | $34.0M | — |
| Q4 25 | $-11.4M | $-61.9M | ||
| Q3 25 | $-12.5M | $-67.3M | ||
| Q2 25 | $-9.0M | $-92.6M | ||
| Q1 25 | $-6.1M | $-129.6M | ||
| Q4 24 | $-10.3M | $-59.2M | ||
| Q3 24 | $-10.4M | $-85.7M | ||
| Q2 24 | $-796.0K | — | ||
| Q1 24 | $-3.7M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -125.6% | -169.0% | ||
| Q3 25 | -47.7% | -173.5% | ||
| Q2 25 | -30.3% | -269.8% | ||
| Q1 25 | -19.0% | -390.1% | ||
| Q4 24 | -128.8% | -919.0% | ||
| Q3 24 | -36.9% | -1314.3% | ||
| Q2 24 | -1.6% | — | ||
| Q1 24 | -10.7% | — |
| Q4 25 | -125.8% | -161.8% | ||
| Q3 25 | -47.5% | -209.8% | ||
| Q2 25 | -30.3% | -350.3% | ||
| Q1 25 | -18.9% | -784.9% | ||
| Q4 24 | -129.8% | -783.4% | ||
| Q3 24 | -36.3% | -1404.0% | ||
| Q2 24 | -2.3% | — | ||
| Q1 24 | -11.0% | — |
| Q4 25 | $-3.89 | $-0.06 | ||
| Q3 25 | $-23.52 | $-0.07 | ||
| Q2 25 | $-18.94 | $-0.10 | ||
| Q1 25 | $-20.73 | $-0.15 | ||
| Q4 24 | $97.71 | $-0.08 | ||
| Q3 24 | $-305.04 | $-0.14 | ||
| Q2 24 | $-98.64 | — | ||
| Q1 24 | $-125.46 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.4M | $242.8M |
| Total DebtLower is stronger | $509.8M | — |
| Stockholders' EquityBook value | $265.4M | $-500.5M |
| Total Assets | $859.2M | $501.9M |
| Debt / EquityLower = less leverage | 1.92× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.4M | $242.8M | ||
| Q3 25 | $17.3M | $257.8M | ||
| Q2 25 | $27.8M | $153.7M | ||
| Q1 25 | $19.8M | $61.6M | ||
| Q4 24 | $20.3M | $149.8M | ||
| Q3 24 | $18.5M | $130.4M | ||
| Q2 24 | $29.3M | — | ||
| Q1 24 | $21.3M | — |
| Q4 25 | $509.8M | — | ||
| Q3 25 | $527.8M | — | ||
| Q2 25 | $535.6M | — | ||
| Q1 25 | $512.7M | — | ||
| Q4 24 | $505.7M | — | ||
| Q3 24 | $478.3M | — | ||
| Q2 24 | $485.1M | — | ||
| Q1 24 | $472.8M | — |
| Q4 25 | $265.4M | $-500.5M | ||
| Q3 25 | $281.9M | $-524.3M | ||
| Q2 25 | $287.1M | $-570.7M | ||
| Q1 25 | $293.0M | $-591.4M | ||
| Q4 24 | $304.5M | $-489.1M | ||
| Q3 24 | $321.0M | $-745.1M | ||
| Q2 24 | $351.1M | — | ||
| Q1 24 | $369.9M | — |
| Q4 25 | $859.2M | $501.9M | ||
| Q3 25 | $871.8M | $519.0M | ||
| Q2 25 | $885.0M | $402.1M | ||
| Q1 25 | $882.3M | $303.8M | ||
| Q4 24 | $889.6M | $382.9M | ||
| Q3 24 | $868.0M | $364.6M | ||
| Q2 24 | $891.2M | — | ||
| Q1 24 | $887.5M | — |
| Q4 25 | 1.92× | — | ||
| Q3 25 | 1.87× | — | ||
| Q2 25 | 1.87× | — | ||
| Q1 25 | 1.75× | — | ||
| Q4 24 | 1.66× | — | ||
| Q3 24 | 1.49× | — | ||
| Q2 24 | 1.38× | — | ||
| Q1 24 | 1.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.8M | $-70.4M |
| Free Cash FlowOCF − Capex | — | $-71.3M |
| FCF MarginFCF / Revenue | — | -186.2% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.8M | $-70.4M | ||
| Q3 25 | $3.7M | $-68.9M | ||
| Q2 25 | $-2.5M | $-79.7M | ||
| Q1 25 | $1.2M | $-85.9M | ||
| Q4 24 | $17.0M | $-85.1M | ||
| Q3 24 | $10.3M | $-98.8M | ||
| Q2 24 | $3.9M | — | ||
| Q1 24 | $1.6M | — |
| Q4 25 | — | $-71.3M | ||
| Q3 25 | — | $-69.6M | ||
| Q2 25 | — | $-80.8M | ||
| Q1 25 | — | $-87.0M | ||
| Q4 24 | — | $-87.3M | ||
| Q3 24 | — | $-101.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -186.2% | ||
| Q3 25 | — | -217.2% | ||
| Q2 25 | — | -305.9% | ||
| Q1 25 | — | -526.9% | ||
| Q4 24 | — | -1155.4% | ||
| Q3 24 | — | -1663.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | — | 45.7% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
